TY - JOUR
T1 - Streptokinase - The drug of choice for thrombolytic therapy
AU - Kunamneni, Adinarayana
AU - Abdelghani, Thaer Taleb Abed
AU - Ellaiah, Poluri
N1 - Funding Information:
Acknowledgements The authors are thankful to Andhra University, Visakhapatnam, India and Council of Scientific & Industrial Research (CSIR), New Delhi, India, for providing financial support and awarding a senior research fellowship (Award No. 9/2 (454)/2k2, EMR.I) to Dr. Adinarayana Kunamneni.
PY - 2007/2
Y1 - 2007/2
N2 - Thrombosis, the blockage of blood vessels with clots, can lead to acute myocardial infarction and ischemic stroke, both leading causes of death. Other than surgical interventions to remove or by pass the blockage, or the generation of collateral vessels to provide a new blood supply, the only treatment available is the administration of thrombolytic agents to dissolve the blood clot. This article describes a comprehensive review of streptokinase (SK). We discuss the biochemistry and molecular biology of SK, describing the mechanism of action, structures, confirmational properties, immunogenecity, chemical modification, and cloning and expression. The production and physico-chemical properties of this SK are also discussed. In this review, considering the properties and characteristics of SK that make it the drug of choice for thrombolytic therapy.
AB - Thrombosis, the blockage of blood vessels with clots, can lead to acute myocardial infarction and ischemic stroke, both leading causes of death. Other than surgical interventions to remove or by pass the blockage, or the generation of collateral vessels to provide a new blood supply, the only treatment available is the administration of thrombolytic agents to dissolve the blood clot. This article describes a comprehensive review of streptokinase (SK). We discuss the biochemistry and molecular biology of SK, describing the mechanism of action, structures, confirmational properties, immunogenecity, chemical modification, and cloning and expression. The production and physico-chemical properties of this SK are also discussed. In this review, considering the properties and characteristics of SK that make it the drug of choice for thrombolytic therapy.
KW - Fibrinolysis
KW - Plasminogen activators
KW - Streptokinase (SK)
KW - Thrombolytic therapy
UR - http://www.scopus.com/inward/record.url?scp=33846965280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846965280&partnerID=8YFLogxK
U2 - 10.1007/s11239-006-9011-x
DO - 10.1007/s11239-006-9011-x
M3 - Review article
C2 - 17111203
AN - SCOPUS:33846965280
SN - 0929-5305
VL - 23
SP - 9
EP - 23
JO - Journal of Thrombosis and Thrombolysis
JF - Journal of Thrombosis and Thrombolysis
IS - 1
ER -